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Abstract 
Objectives: Bipolar disorder (BPD) shares genetic components with other psychiatric disorders; 
however, uncertainty remains about where in the psychiatric spectra BPD falls. To understand 
the etiology of BPD, we studied the familial aggregation of BPD and co-aggregation between 
BPD and schizophrenia, schizoaffective disorder, depression, anxiety disorders, attention 
deficit/hyperactivity disorder (ADHD), drug abuse, personality disorders and autism spectrum 
disorders (ASD).  
Methods: A population-based cohort was created by linking several Swedish national registers. 
54,723 BPD individuals were identified among 8,141,033 offspring from 4,149,748 nuclear 
families. The relative risk of BPD in relatives and co-occurrence of other psychiatric disorders in 
BPD patients and their relatives were compared to those of matched population controls. 
Structural equation modeling was used to estimate the heritability and tetrachoric correlation. 
Results: The familial risks for relatives of BPD probands were 5.8-7.9 in first degree relatives, 
and decreased with genetic distance. Co-occurrence risks for other psychiatric disorders were 
9.7-26.4 in BPD individuals and 1.7-2.8 in full siblings of BPD probands. Heritability for BPD 
was estimated at 58%. The correlations between BPD and other psychiatric disorders were 
considerable (0.37-0.62) and primarily due to genetic effects.  The correlation with depression 
was the highest (0.62), but was only 0.44 for schizophrenia. 
Conclusions: The high  familial risks provides evidence that genetic factors play an important 
role in the etiology of BPD, and the shared genetic determinants suggest pleiotropic effects 
across different psychiatric disorders. Results also indicate BPD is in both the mood and 
psychotic spectra, but possibly more closely related to mood disorders. 
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Introduction 
Recently published studies have shown shared genetic effects between major psychiatric 
disorders including bipolar disorder (BPD) (1, 2), but it remains unclear where BPD falls among 
psychiatric disorders. BPD has long been treated as a mood disorder from traditional symptom 
diagnoses, but recent studies have emphasized its correlation with schizophrenia, a psychotic 
disorder (3-5). Estimates of  familial risks and heritability help quantify the magnitude of genetic 
and environmental influences on BPD, and co-occurrence and correlations between BPD and 
other psychiatric disorders can provide crucial information about the position of BPD among 
major psychiatric disorders.  
Twin, adoption and family studies (4-11) have shown that genes influence the familial 
transmission for BPD, even though questions remain regarding the magnitude of the heritability 
and whether sex-specific effects exist. Also, risk estimates in second and third degree relatives, 
spouses, and adoptive relatives of individuals with BPD have been limited.  
Observed co-occurrences between BPD and several psychiatric conditions (e.g., depression 
(12), schizophrenia (12, 13) and schizoaffective disorder (14)) within the same individuals over 
time as well as in family members, are partly due to shared genetic determinants. We previously 
reported that about 50% of the genetic determinants overlap in BPD and schizophrenia (4), 
which is in line with results from genome-wide association studies (GWAS) (15). In addition, we 
have found evidence for shared genetic factors between BPD and attention deficit/hyperactivity 
disorder (ADHD) (16), as well as between BPD and autism spectrum disorders (ASD) (17). 
However, the co-occurrence risk estimates vary across studies (9, 10), and the relative 
importance of genetic factors for these overlaps has not been estimated.   
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Our aim was to provide reliable estimates of familial risk of BPD and explore the etiologic 
overlap with other psychiatric disorders by using data from the total Swedish population (N=9 
million individuals). Specifically, we aimed to: (1) provide improved estimates of  familial risks 
and heritability for BPD; (2) study the individual and familial co-occurrence of other psychiatric 
disorders for BPD; (3) Estimate the genetic overlaps between BPD and other psychiatric 
disorders to determine shared genetic and/or environmental effects. 
 
Methods 
National registers 
We established a population-based national cohort through linkage of several longitudinal 
Swedish total population registers, using the personal identification numbers unique to each 
individual. The National Patient Register (NPR) captures all public psychiatric inpatient 
admissions in Sweden since 1973 and outpatient diagnoses since 2001. Each record contains 
admission and discharge dates, the main discharge diagnosis, and up to eight secondary 
diagnoses assigned by the attending physician in accordance with International Classification of 
Diseases (ICD) system. The Multi-Generation Register (MGR) enabled identification of 
biological and adoptive parents of all individuals registered as living in Sweden since 1961 and 
born in Sweden since 1932. The Swedish Twin Register covers all twins born in Sweden since 
1886. The Total Population Register (TPR), Cause of Death Register and Migration Register 
provided information on individuals’ sex, date of birth, and when and where they were alive and 
living in Sweden. All registries were followed from their start to 2009. Ethical approval was 
given by the ethics committee at Karolinska Institutet. 
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We identified 8,141,033 offspring clustered into 4,149,748 nuclear families. Using the NPR 
and TPR we found probands with BPD and the controls. Through the MGR we identified their 
first, second and third degree relatives, mating partners and adoptive relatives. In analyses of 
adoptions, we excluded adoptive parents who have biological relationships (grandparents, uncles 
or aunts) with their adoptee and siblings who have biological relationships (cousins) with their 
adoptive siblings.  
For heritability analyses, we established a cohort of siblings born from 1958 to 1985 with 
follow-up time from 1973 to 2009, which included monozygotic (MZ) twins, dizygotic (DZ) 
twins, full siblings and half-siblings after exclusion of those died or emigrated before age 25. To 
simplify the analysis, we randomly selected one sibling pair from each sibling structure, giving 
priority to twins, followed by maternal siblings, paternal siblings and full siblings in order to 
maximize sample size in each class of sibling structure. To increase comparability, we only 
selected the eldest siblings born within 5 years of each other. Our cohort contained 5,773 MZ 
twin pairs, 17,053 DZ pairs, 35,017 maternal half-sibling pairs, 24,289 paternal half-sibling pairs 
and 638,295 full sibling pairs.    
Disease classifications 
Diagnoses were coded according to ICD-8 (1969-1986), ICD-9 (1987-1996) and ICD-10 (1997- 
present) using a non-hierarchical diagnostic structure. We extracted bipolar patients with high 
specificity from the NPR by applying a validated algorithm (18), where BPD was defined as at 
least two inpatient or outpatient admissions for a core BPD diagnosis (ICD-8: 296.0- 296.3, 
296.8, 296.9; ICD-9: 296A-296E, 296W, 296X; ICD-10: F30, F31), with exclusion of sole 
diagnoses of ICD-8 296.2 (manic-depressive psychosis, depressed type) and/or ICD-9 296B 
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(unipolar affective psychosis, melancholic form). Schizophrenia, schizoaffective disorder, 
depression, anxiety disorders, ADHD, drug abuse, personality disorders and ASD were defined 
by one or two of their core diagnosis codes (see Table S1 in the online data supplement). 
Statistical analysis 
We refer to relative risk (RR) for the measure of familial risk and co-occurrence risk throughout 
the manuscript. To estimate  familial risk for BPD, we estimated the risk of relatives to 
individuals with BPD compared to relatives of up to ten randomly selected individuals 
unaffected by BPD, matched by sex and year of birth. To ensure equal follow-up time, the 
control was required to be alive, reside in Sweden, and have no history of BPD before the date of 
the first diagnosis of the matched proband. To allow equal possibility for diagnosis of BPD, the 
proband and matched controls were required to live in the same county in the year when the 
proband was diagnosed BPD (because counties began reporting to the registry at different times). 
This county-matching qualification was not conducted in adoptive relationships to maximize 
sample size. In addition, to ensure equal time at risk, the relative of the control was also matched 
to the relative of the proband by biological relationship, sex, and year of birth.    
For co-occurrence of other psychiatric disorders within individuals with BPD, ten controls 
were randomly selected for each BPD proband with the same strategy (i.e., matched on sex, year 
of birth, living area when the proband was diagnosed BPD; to be alive, reside in Sweden, and 
with no history of BPD before the date of the first diagnosis of the matched proband). Selection 
measures for estimates of the familial co-occurrence risk were also the same as that in the  
familial risk for BPD. To ensure that the observed associations in analyses were between BPD in 
the proband and psychiatric disorders in the relative, we excluded relatives ever diagnosed with 
8 
 
BPD. Furthermore, we conducted sensitivity analyses excluding the possibility of diagnoses of 
both disorders within individuals in full siblings. For example, when estimating the co-
occurrence risk between BPD and schizophrenia, we excluded BPD probands ever diagnosed 
with schizophrenia and excluded siblings ever diagnosed with BPD.  
We estimated the associations using conditional logistic regression models with PROC 
PHREG in SAS 9.3 (19). Since several correlated pairs of relatives from each family were 
sometimes included in the analyses, a robust sandwich estimator was used to adjust for the non-
independent data structure when calculating the 95% confidence intervals (4, 20, 21). 
Structural equation modeling was used to estimate the heritability. We treated the disease 
status as a binary variable and employed the liability-threshold model (22). For each diagnosis, 
we allowed for different prevalence of the outcome in the five different types of siblings, and 
adjusted prevalence for sex effects assumed to be identical between all sibling types. The genetic 
correlation was fixed to 1 for MZ twin pairs (they are genetically identical), to 0.5 for DZ twins 
and full siblings (they share on average 50% of their segregating genes), and to 0.25 for half-
siblings. We assumed that the family environment is shared between MZ twins, DZ twins, full 
siblings and maternal half-siblings (the family environmental correlation was fixed to 1), but 
unshared between paternal half-siblings (22). We assumed that there are no epistasis or 
dominance deviations between genes and no interactions or correlations between genetic and 
environmental components. Data were first analyzed with a univariate model using the Mx 
progam (23). Then we used a bivariate Cholesky decomposition (24) to calculate the tetrachoric 
correlations to estimate the relative contribution of genetic and environment elements in common 
with BPD to the liability of another disorder (See Methods in the online data supplement for 
more details).     
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Results 
Familial risks for BPD 
There were 54,723 individuals who met our criteria for BPD. We have previously presented the 
results for parent/offspring, sibling, half/sibling and adoptive relationships with inpatient data (4). 
Here we extended our previous work by including 5 more years of follow-up of inpatient data 
and outpatient data since 2001, and by also estimating the risks for other biological and adoptive 
relationships (Table 1).  
{Table 1 approximately here} 
Similar to prior results, the relatives of individuals with BPD had increased risks for BPD, and 
risks decreased with the distance of biological relationships (RR first degree=5.8-7.9 > RR second degree 
=2.2-3.3> RR third degree=1.6). Despite the lack of sex differences for the risks in first-degree 
relatives, male relatives of male probands tend to have higher risks (RR = 7.4-7.9). We found a 
suggestive difference in RRs between maternal half-siblings and paternal half-siblings of BPD 
probands; among the 6,895 maternal half-siblings, 139 were diagnosed with BPD (RR=3.3 (2.6-
4.2)), whereas 101 were diagnosed with BPD among the 8,941 paternal half-siblings (RR=2.2 
(1.7-2.9)). Notably, the RR of maternal half-siblings was not only higher than paternal half-
siblings but also for any other class of second-degree relatives. Furthermore, there was 
substantial evidence for assortative mating for BPD (RR=2.1 (1.9-2.3)). Additionally, adopted 
children whose biological parents had BPD (N=503), or biological parents whose adopted away 
children had BPD (N=578), also had increased risk of being diagnosed with BPD (RR=4.5 (2.6-
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7.6) and 5.0 (2.9-8.5)). We also observed significantly increased, but relatively lower, risks of 
BPD in adoptee/adoptive parent and adoptive parent/adoptee relationships.  
Co-occurrence risk for psychiatric disorders within individuals with BPD 
Among the 54,723 patients diagnosed with BPD, a number of patients had at some point also had 
been diagnosed with schizophrenia (N=3,320), depression (N=22,433), anxiety disorders 
(N=14,563), ADHD (N=2,064), drug abuse (N=5,733), personality disorders (N=8,473) or ASD 
(N=776) (Table 2). There were substantially increased risks for all of these psychiatric disorders 
(RR 9.7-22.9) in individuals with BPD when compared to population controls. We did not 
estimate the RR for depression for individuals with BPD, because those who were diagnosed 
with BPD will experience depressive episodes during their lifetime. However, we did include the 
estimates of RR for depression for relatives of BPD probands since relatives who were diagnosed 
with BPD were excluded. 
It is notable that about half of the patients with schizoaffective disorder were also diagnosed with 
BPD (N=4,332 from 10,750 individuals with schizoaffective disorder). Thus, we did not show 
the results for schizoaffective disorder, because it’s questionable that these are distinguishable 
disorders in our sample.  
{Table 2 approximately here} 
Co-occurrence risk for psychiatric disorders among relatives of BPD probands 
Our previous studies have shown the familial aggregation between BPD and schizophrenia (4), 
BPD and ADHD (16) and BPD and ASD (17). This study extended investigations to depression, 
anxiety disorders, drug abuse and personality disorders in the first, second, third degree and 
adoptive relatives of BPD probands. Table 3 displays the results for different sibling types 
11 
 
(results for all types of relationships are shown in supplemental tables S2-S8 online). Full 
siblings of BPD probands had significantly increased risks for all disorders investigated 
(RR=1.7-2.8), and in sensitivity analyses (i.e., excluding the possibility that individuals could be 
diagnosed with both disorders) these co-occurrences were somewhat attenuated but still 
significant (RR = 1.4-2.6; see supplemental Table S9 online). Full siblings had higher risks for 
co-occurrence compared to half-siblings; maternal half-siblings had slightly higher risks than 
paternal half-siblings (except for schizophrenia). Adopted away siblings, whose biological 
sibling had BPD and grew up in a different family, also had increased risks for depression, 
anxiety disorders, drug abuse and personality disorders. Similar patterns of significantly 
increased risks appeared for all the disorders among first-degree relatives of BPD probands (see 
supplemental Table S2-S8 online). From these results, we noted high risks for ASD for adopted 
away biological offspring of parents with BPD (RR=5.5 (1.6-18.4)) and for adoptees of adoptive 
parents with BPD (RR=2.2 (1.2-3.9)) (see supplemental Table S8 online).  
{Table 3 approximately here} 
Heritability 
We estimated the heritability for BPD at 58%, and the remaining variance was attributed to non-
shared environmental effects (Table 4). We next performed bivariate correlation analyses 
between BPD and other psychiatric disorders, summarized in Figure 1 (estimates of parameters 
and correlations in supplemental Table S10-S11 online). The tetrachoric correlations were 
considerable (0.37-0.62), and the highest correlation was between BPD and depression (0.62). 
Genetic effects accounted for approximately 1/2 of the correlations; for schizophrenia, ADHD 
and ASD the proportion achieved 2/3. 
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{Table 4 approximately here} 
{Figure 1 approximately here} 
 
Discussion 
In this population-based study with the largest BPD cohort ever published, we found: (1) strong 
familial risks for BPD; (2) strong co-occurrence risks for schizophrenia,  anxiety disorders, 
ADHD, drug abuse, personality disorders and ASD in individuals with BPD; (3) high familial 
risks for the co-occurrence for schizophrenia, depression, anxiety disorders, ADHD, drug abuse, 
personality disorders and ASD among family members of BPD probands; (4) associations 
between BPD and these psychiatric disorders are to a large extent explained by shared genetic 
factors. These results confirm the importance of genetic risk factors in the etiology of BPD, as 
well as their pleiotropic effects for other psychiatric disorders.  
The estimates of familial risks for BPD align with previous family and adoption studies but 
have higher precision. We confirmed the excess risk for BPD among first degree relatives of 
BPD probands suggested by previous studies. For example, the RRs among first degree relatives 
(6.4-6.8) were similar to the pooled OR (6.96) from a meta-analysis (25). The results for 
parent/offspring, sibling, half/sibling and adoptive relationships are close, if not identical, to 
those from our previous work (4). We have now extended the estimates and confidence intervals 
for essentially all classes of relatives. The tendency for decreasing  RRs with the distance of 
biological relationship, the higher  RR for full siblings compared to maternal half-siblings (these 
two types of siblings are likely to be exposed to similar degree of shared environment), and the 
high RRs for adopted away biological relatives all suggest strong genetic effects for the 
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development of BPD. The estimate of heritability of BPD (58%) is lower than that in a summary 
of twin studies (85%) (26) and the estimate from a review of psychiatric disorders (75%) (27), 
but practically identical to our previous result (59%) which was based on another family model 
(i.e., parent/offspring model) that rests on different assumptions (4). Moreover, our result is 
consistent with another large genetic study (2) which offers a lower bound of heritability by 
using common variants from GWAS data, and our estimation, without specifying genetic 
variants, is likely closer to the true heritability. Compared to twin models on the same data, 
sibling models may yield up to a hundred-fold increase in sample size (thirty-fold increase in our 
sample) and provide more credible assumptions about genetic covariance (28). However, sibling 
models might slightly underestimate the heritability in situations like assortative mating. Our 
estimate is lower than that from twin studies (11, 26). Nevertheless, both these methods and 
molecular genetics studies (5, 11) confirm that genetic factors play a significant etiologic role.  
The higher risk for BPD in maternal half-siblings compared to paternal half-siblings and the 
significantly increased risk for BPD in adoptees to biologically unrelated parents with BPD 
suggested shared environmental effects that were not evident in the heritability analyses (where 
shared environments were estimated at 0). This highlights the need for studies of the effects of 
growing up in families with parents who have BPD. 
Finding increased co-occurrence risks between BPD and major psychiatric disorders within 
individuals was expected. Our results agree with studies on shared genetic effects with 
schizophrenia (1, 15), and on co-occurrence with anxiety disorders - consistent with the results in 
STEP-BD projects (29). Co-occurrences with ADHD (30, 31), personality disorders (32), drug 
abuse (33, 34) and ASD (35) were also verified.  
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Interestingly, we found increased risks for psychiatric disorders among the relatives of 
individuals with BPD (which was significant in full siblings even when individuals could not 
have both BPD and another disorder). These results are congruent with recently published high 
quality GWAS studies (1, 2, 36). Here we also estimated the magnitude of the tetrachoric 
correlations (ranging between 0.37 and 0.76), and 42% to 67% of these associations were 
explained by shared genetic factors. Both familial co-occurrence and correlations across 
psychiatric disorders strengthen the evidence that BPD risk genes contribute to the development 
of different psychiatric disorders, suggesting pleiotropy of genes contributing to psychiatric 
etiology and challenging the current descriptive diagnostic schema (37). In etiological and 
pathophysiological investigations, it may be better to break traditional diagnostic boundaries and 
conceptualize psychiatric disorders as syndromes of “inter-related clinical phenotypes” rather 
than isolating them and assigning the concept of “common comorbidity” (37). Moreover, as 
correlations are less affected by prevalence of diseases and provide more information in 
measuring associations than relative measures of risk, the highest correlation here, with 
depression, showed that BPD may be closer to mood disorders than psychosis among the “inter-
related phenotypes”.   
Non-shared environmental liability to the co-occurrence also cannot be ignored, which is 
evident from its considerable contribution to the correlations (33% to 58%) between bipolar and 
other psychiatric disorders. Prenatal or perinatal complications or history of substance abuse are 
likely to contribute to this kind of environmental source (38).     
We also noticed some interesting features in our data meriting additional investigation. First, 
although no marked sex effects were found, the familial risks for male-male relationships (son-
father, father-son, and male full siblings) were slightly higher than for other relationships 
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(female-male, male-female and female-female relationships). Second, in agreement with a 
previous study (39), we identified a relatively high degree of assortative mating. Third, RRs of 
co-occurrence between BPD and ASD were rather high both among biological and adoptive 
parents of BPD adoptees (see supplemental Table S8 online). Although our study is the largest 
adoption study presented, the limited sample size and inherent assumptions (e.g., selective 
placement, age at adoption) constrain the possibility for firm conclusions.   
The large nationwide sample is a considerable strength. We studied medical records from the 
entire Swedish population spanning more than 30 years, which reduced the risk of 
misclassification by recall and reporting biases. Nevertheless, several limitations exist in our 
studies. (1) Despite the substantial advantages afforded by the population-based studies, a typical 
drawback is the use of non-standardized diagnoses from different physicians with different 
opinions across time and geographic region. However, we used a validated algorithm that has 
been shown to have a positive predictive value of 0.92 and low false-positive rate (18). (2) To 
study the co-occurrence within individuals, a non-hierarchical structure was applied in the 
definition of psychiatric disorders, and we did not consider the order of diagnoses. Since it is not 
uncommon that an individual first diagnosed with depression later develops BPD, or suffers from 
BPD but develops schizophrenia over time, misdiagnoses are inevitable and would affect the 
estimate results. We additionally estimated familial risks and co-occurrence risks with a 
hierarchical definition for schizophrenia, schizoaffective disorder (i.e., excluding those ever 
diagnosed with schizophrenia), and BPD (i.e., excluding those ever diagnosed with 
schizophrenia or schizoaffective disorder) and obtained similar results (data not shown). 
Furthermore, a sensitivity analysis was conducted for the familial co-occurrence between those 
psychiatric disorders and BPD among siblings excluding the possibility of assigning both 
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diagnosis (i.e., when estimating the co-occurrence risk between BPD and another diagnoses like 
drug abuse, we excluded siblings ever diagnosed with BPD; Table S9), and RRs remained 
significant. (3) Diagnostic bias could occur if physicians were influenced by family psychiatric 
history in diagnostic assessments, although adoptive relationships are likely to avoid such bias. 
(4) Clinical diagnosis was the diagnostic procedure of our study and because it is possible that 
sensitivity and negative predictive value for BPD were relatively poor in the early study period, 
clinical features that were more likely to be correctly diagnosed (classical grandiotic-euphoric 
mania, psychotic features, BPD type I) during earlier time might have impacted the results. (5) In 
a similar vein, our study reported estimates for BPD without separating BPD subtypes because of 
the limited information in the Swedish National Register. Future investigation of the familial 
risks and heritability for BPD-I and BPD-II would advance knowledge and further inform the 
etiology for BPD and nosology for psychiatric disorders. (6) For some psychiatric disorders, 
inpatient or outpatient admissions are unusual or atypical. For example, an individual with 
personality disorders is unlikely to be diagnosed; however, if the individual also has BPD, he or 
she will be more likely to visit a physician and also, consequently, be diagnosed with personality 
disorders. Such biases could exist in our estimates of co-occurrence within BPD individuals, but 
is less likely in their relatives for whom BPD was an exclusion criterion.         
Overall, we confirmed and extended the familial risk estimates for BPD and found evidence 
that BPD partly shares genetic causes with other psychiatric disorders. Our findings corroborate 
recent molecular genetic studies (1, 2) showing abundant pleiotropy of gene variants in 
psychiatry. Moreover, we showed that BPD is highly correlated with depression, highlighting 
that the communality between BPD and depression should not be forgotten. Precision of 
estimates of familial risks and the magnitude of genetic influences provide crucial parameters 
17 
 
(i.e., estimate of strength of genetic transmission, quantification of risk at the population level) 
for the design and interpretation of genetic studies and identification of meaningful 
endophenotypes. From a clinical perspective, the feature of familial risks may offer a rationale to 
initiate preventive family-based screening in primary care. The knowledge of co-occurrence 
might contribute to future nosology of psychiatric disorders through incorporation of genetic 
factors and other levels of information to lay the foundation for a more precise diagnostic system; 
thus yielding better treatments and medications for patients. 
 
18 
 
Acknowledgements 
This study was supported by the Swedish Council for Working Life and Social Research, the 
Swedish Research Council and the China Scholarship Council. 
Disclosures 
All authors report no financial relationships with commercial interests.  
19 
 
References 
 
1. Cross-Disorder Group of the Psychiatric Genomics C. Identification of risk loci with shared 
effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013. 
2. Cross-Disorder Group of the Psychiatric Genomics C. Genetic relationship between five 
psychiatric disorders estimated from genome-wide SNPs. Nature Genetics (in press). 2013. 
3. Steinberg S, de Jong S, Mattheisen M, et al. Common variant at 16p11.2 conferring risk of 
psychosis. Mol Psychiatry. 2012. 
4. Lichtenstein P, Yip BH, Bjork C, et al. Common genetic determinants of schizophrenia and 
bipolar disorder in Swedish families: a population-based study. Lancet. 2009; 373:234-9. 
5. Craddock N, Sklar P. Genetics of bipolar disorder. The Lancet. 2013; 381:1654-62. 
6. Kendler KS, Pedersen N, Johnson L, Neale MC, Mathe AA. A pilot Swedish twin study of 
affective illness, including hospital- and population-ascertained subsamples. Arch Gen Psychiatry. 1993; 
50:699-700. 
7. Wender PH, Kety SS, Rosenthal D, Schulsinger F, Ortmann J, Lunde I. Psychiatric disorders in 
the biological and adoptive families of adopted individuals with affective disorders. Arch Gen Psychiatry. 
1986; 43:923-9. 
8. Weissman MM, Gershon ES, Kidd KK, et al. Psychiatric disorders in the relatives of probands 
with affective disorders. The Yale University--National Institute of Mental Health Collaborative Study. 
Arch Gen Psychiatry. 1984; 41:13-21. 
9. Smoller JW, Finn CT. Family, twin, and adoption studies of bipolar disorder. American journal of 
medical genetics Part C, Seminars in medical genetics. 2003; 123C:48-58. 
10. Merikangas K, Yu K. Genetic epidemiology of bipolar disorder. Clin Neurosci Res. 2002; 2:127-
41. 
11. Barnett JH, Smoller JW. The genetics of bipolar disorder. Neuroscience. 2009; 164:331-43. 
12. Tsuang MT, Winokur G, Crowe RR. Morbidity risks of schizophrenia and affective disorders 
among first degree relatives of patients with schizophrenia, mania, depression and surgical conditions. 
The British journal of psychiatry : the journal of mental science. 1980; 137:497-504. 
13. Taylor MA, Berenbaum SA, Jampala VC, Cloninger CR. Are schizophrenia and affective 
disorder related? preliminary data from a family study. The American journal of psychiatry. 1993; 
150:278-85. 
14. Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin P. A twin study of genetic 
relationships between psychotic symptoms. The American journal of psychiatry. 2002; 159:539-45. 
15. International Schizophrenia C, Purcell SM, Wray NR, et al. Common polygenic variation 
contributes to risk of schizophrenia and bipolar disorder. Nature. 2009; 460:748-52. 
16. Larsson H, Ryden E, Boman M, Langstrom N, Lichtenstein P, Landen M. Risk of bipolar 
disorder and schizophrenia in relatives of people with attention-deficit hyperactivity disorder. The British 
journal of psychiatry : the journal of mental science. 2013. 
17. Sullivan PF, Magnusson C, Reichenberg A, et al. Family history of schizophrenia and bipolar 
disorder as risk factors for autism. Arch Gen Psychiatry. 2012; 69:1099-103. 
18. Sellgren C, Landen M, Lichtenstein P, Hultman CM, Langstrom N. Validity of bipolar disorder 
hospital discharge diagnoses: file review and multiple register linkage in Sweden. Acta psychiatrica 
Scandinavica. 2011; 124:447-53. 
19. Inc SI. SAS® 9.3 Intelligence Platform: Migration Guide. Cary, NC: SAS Institute Inc. 2011. 
20. Frisell T, Lichtenstein P, Langstrom N. Violent crime runs in families: a total population study of 
12.5 million individuals. Psychological medicine. 2011; 41:97-105. 
21. Kyaga S, Landen M, Boman M, Hultman CM, Langstrom N, Lichtenstein P. Mental illness, 
suicide and creativity: 40-year prospective total population study. Journal of psychiatric research. 2013; 
47:83-90. 
20 
 
22. Neale MC, Maes HHM. Methodology for Genetic Studies of Twins and Families. 2004:43-7. 
23. Neale MC, Boker SM, Xie G, Maes HH. Mx: Statistical Modeling. VCU Box 900126, Richmond, 
VA 23298: Department of Psychiatry 7th Edition. 2006. 
24. Loehlin JC. The Cholesky approach: A cautionary note. Behavior genetics. 1996; 26:65-9. 
25. Wozniak J, Faraone SV, Martelon M, McKillop HN, Biederman J. Further evidence for robust 
familiality of pediatric bipolar I disorder: results from a very large controlled family study of pediatric 
bipolar I disorder and a meta-analysis. The Journal of clinical psychiatry. 2012; 73:1328-34. 
26. Bienvenu OJ, Davydow DS, Kendler KS. Psychiatric 'diseases' versus behavioral disorders and 
degree of genetic influence. Psychological medicine. 2011; 41:33-40. 
27. Sullivan PF, Daly MJ, O'Donovan M. Genetic architectures of psychiatric disorders: the emerging 
picture and its implications. Nature reviews Genetics. 2012; 13:537-51. 
28. Frisell T, Pawitan Y, Langstrom N, Lichtenstein P. Heritability, assortative mating and gender 
differences in violent crime: results from a total population sample using twin, adoption, and sibling 
models. Behavior genetics. 2012; 42:3-18. 
29. Simon NM, Otto MW, Wisniewski SR, et al. Anxiety disorder comorbidity in bipolar disorder 
patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for 
Bipolar Disorder (STEP-BD). The American journal of psychiatry. 2004; 161:2222-9. 
30. Singh MK, DelBello MP, Kowatch RA, Strakowski SM. Co-occurrence of bipolar and attention-
deficit hyperactivity disorders in children. Bipolar disorders. 2006; 8:710-20. 
31. Ryden E, Thase ME, Straht D, Aberg-Wistedt A, Bejerot S, Landen M. A history of childhood 
attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients 
regardless of current ADHD. Acta psychiatrica Scandinavica. 2009; 120:239-46. 
32. Garno JL, Goldberg JF, Ramirez PM, Ritzler BA. Bipolar disorder with comorbid cluster B 
personality disorder features: impact on suicidality. The Journal of clinical psychiatry. 2005; 66:339-45. 
33. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other 
drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA : the journal of the 
American Medical Association. 1990; 264:2511-8. 
34. Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar disorders. 2001; 
3:181-8. 
35. Joshi G, Biederman J, Petty C, Goldin RL, Wozniak J. Examining the Comorbidity of Bipolar 
Disorder and Autism Spectrum Disorders: A Large Controlled Analysis of Phenotypic and Familial 
Correlates in Youth with Bipolar Disorder. Eur Psychiat. 2012; 27. 
36. Serretti A, Fabbri C. Shared genetics among major psychiatric disorders. Lancet. 2013. 
37. Nasrallah HA. Pleiotropy of psychiatric disorders will reinvent DSM. Current Psychiatry. 2013; 
12:2. 
38. Plomin R, Daniels D. Why are children in the same family so different from one another?*. Int J 
Epidemiol. 2011; 40:563-82. 
39. Mathews CA, Reus VI. Assortative mating in the affective disorders: a systematic review and 
meta-analysis. Comprehensive psychiatry. 2001; 42:257-62. 
 
21 
 
Table 1. Familial risks for BPD in relatives of individuals with BPD  
Relative class Relation to proband Grouping 
Relatives affected with BPD 
RR 95%CI With BPD 
probands (%) 
General 
population 
controls (%) 
Biological relationship       
First degree Parent Total 2119 (3.1) 3269 (0.5) 6.7 6.3-7.0 
Father 789 (2.4) 1153 (0.4) 7.0 6.4-7.5 
  Male offspring-father 364 (2.7) 474 (0.4) 7.9 7.0-8.9 
  Female offspring-father 425 (2.2) 702 (0.4) 6.1 5.5-6.8 
Mother 1330 (3.9) 2123 (0.6) 6.4 6.0-6.8 
  Male offspring-mother 546 (3.9) 891 (0.6) 6.3 5.8-7.0 
  Female offspring-mother 784 (3.9) 1248 (0.6) 6.5 6.0-7.0 
Offspring Total 2119 (2.8) 3216 (0.4) 6.8 6.4-7.1 
BPD in father 785 (2.8) 1157 (0.4) 6.9 6.4-7.5 
  Father proband-son 362 (2.5) 486 (0.3) 7.6 6.7-8.6 
  Father proband-daughter 423 (3.1) 694 (0.5) 6.2 5.6-6.9 
BPD in mother 1334 (2.8) 2065 (0.4) 6.6 6.2-7.1 
  Mother proband-son 548 (2.2) 864 (0.4) 6.5 5.9-7.1 
  Mother proband-daughter 786 (3.4) 1267 (0.6) 6.4 5.9-6.9 
Sibling Total 2142 (3.9) 3429 (0.6) 6.4 6.0-6.8 
  Male proband-female sibling 464 (4.2) 795 (0.7) 5.9 5.3-6.5 
  Male proband-male sibling 442 (3.9) 612 (0.6) 7.4 6.5-8.4 
  Female proband-male sibling 463 (2.8) 814 (0.5) 5.8 5.2-6.4 
  Female proband-female sibling 773 (4.8) 1209 (0.8) 6.6 5.9-7.2 
Second degree Grandparent Total 404 (0.9) 1797 (0.4) 2.3 2.0-2.5 
Uncle/aunt Total 620 (1.5) 2693 (0.7) 2.3 2.1-2.5 
Grandchild Total 407 (0.5) 1713 (0.2) 2.4 2.1-2.6 
Nephew/niece Total 619 (0.7) 2697 ( 0.3) 2.3 2.1-2.5 
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Table 1. (Continued)  
Relative class Relation to proband Grouping 
Relatives affected with BPD 
RR 95%CI With BPD 
probands (%) 
General 
population 
controls (%) 
Second degree Half sibling Paternal half-sibling 101 (1.1) 335 (0.5) 2.2 1.7-2.9 
Maternal half-sibling 139 (2.0) 293 (0.6) 3.3 2.6-4.2 
Third degree Cousin Total 523 (0.6) 3358 (0.4) 1.6 1.4-1.7 
Unrelated Mating partner Total 407 (1.0) 1928 (0.5) 2.1 1.9-2.3 
       
Adoptive relationship       
First degree Biological parent Total 19 (3.8) 38 (0.9) 4.5 2.6-7.6 
 Adopted away biological offspring Total 19 (3.3) 29 (0.7) 5.0 2.9-8.5 
 Adopted away biological sibling Total 12 (7.9) 10 (1.1) 9.9 2.5-40.0 
Unrelated Adoptive parent Total 14 (0.9) 49 (0.3) 2.8 1.7-4.8 
 Adoptee Total 14 (1.8) 44 (0.6) 3.1 1.8-5.4 
 Non-biological sibling Total 12 (2.0) 55 (1.1) 1.8 0.8-4.1 
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Table 2. Risk for psychiatric disorders for individuals with BPD  
Diagnosis Individuals with BPD (N=54328a, %) 
General population controls 
unaffected with BPD 
(N=543280, %) 
RR 95%CI 
Schizophrenia 3320 (6.1) 2320 (0.4) 15.3 14.5-16.2 
     
Anxiety disorders 14563 (26.8) 19614 (3.6) 10.2 9.9-10.4 
ADHD 2064 (3.8) 1105 (0.2) 21.8 20.2-23.6 
Drug abuse 5733 (10.6) 6761 (1.2) 9.7 9.3-10.0 
Personality disorders 8473 (15.6) 4558 (0.8) 22.9 22.0-23.8 
ASD 776 (1.4) 615 (0.1) 13.2 11.9-14.7 
a There are 54328 BPD individuals who have county records used for county matching.
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Table 3. Risk for psychiatric disorders in siblings of individuals with BPD 
 
Relation to proband 
Full sibling Maternal half-sibling 
Paternal half-
sibling 
Adopted away 
biological sibling 
Adopted non-biological 
sibling 
RR 95%CI RR 95%CI RR 95%CI RR 95%CI RR 95%CI 
Schizophrenia 2.8 2.5-3.0 1.3 0.9-1.9 1.6 1.2-2.1 1.5 0.5-4.9 0.8 0.2-3.3 
Depression 2.1 2.0-2.2 1.5 1.3-1.7 1.2 1.0-1.3 2.1 1.0-4.2 1.2 0.8-1.9 
Anxiety disorders 1.8 1.7-1.8 1.3 1.2-1.5 1.2 1.1-1.3 2.1 1.2-3.9 1.1 0.7-1.6 
ADHD 2.4 2.1-2.7 1.5 1.3-1.9 1.2 1.0-1.4 … … 1.5 0.7-2.8 
Drug abuse 1.7 1.6-1.8 1.3 1.1-1.5 1.2 1.0-1.3 2.6 1.3-5.2 1.5 0.9-2.4 
Personality disorders 2.2 2.1-2.4 1.5 1.3-1.8 1.2 1.0-1.4 2.2 1.0-5.0 1.1 0.6-1.8 
ASD 2.6 2.3-3.0 1.6 1.2-2.1 1.2 1.0-1.6 … … 1.5 0.6-4.0 
Abbreviation: Ellipsis, not applicable.
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Table 4. Estimated variance components of the liability of psychiatric disorders 
 
Psychiatric disorder 
Heritability Non-shared environment Shared environment 
Estimates 95%CI Estimates 95%CI Estimates 95%CI 
BPD 58% 42%-64% 42% 36%-51% 0% 0%-8% 
Schizophrenia 76% 69%-83% 24% 17%-33% 0% 0%-0% 
Depression 32% 19%-40% 65% 60%-72% 3% 0%-9% 
Anxiety disorders 41% 31%-43% 59% 57%-64% 0% 0%-5% 
ADHD 64% 52%-71% 36% 29%-44% 0% 0%-0% 
Drug abuse 58% 46%-71% 36% 29%-42% 6% 0%-12% 
Personality disorders 53% 41%-57% 47% 43%-54% 0% 0%-0% 
ASD 67% 23%-77% 32% 23%-55% 1% 0%-22% 
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Figure 1. Tetrachoric correlation between BPD and other psychiatric disorders 
 
